199 related articles for article (PubMed ID: 31797578)
21. Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers.
He YL; Zhang Y; Serra D; Wang Y; Ligueros-Saylan M; Dole WP
Curr Med Res Opin; 2011 Jul; 27(7):1453-63. PubMed ID: 21609207
[TBL] [Abstract][Full Text] [Related]
22. Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects.
Shakeri-Nejad K; Aslanis V; Veldandi UK; Mooney L; Pezous N; Brendani B; Juan A; Allison M; Perry R; Legangneux E
Clin Ther; 2015 Nov; 37(11):2489-2505.e2. PubMed ID: 26519230
[TBL] [Abstract][Full Text] [Related]
23. QT/QTc study conducted in Japanese adult healthy subjects: a novel xanthine oxidase inhibitor topiroxostat was not associated with QT prolongation.
Sugiyama A; Hashimoto H; Nakamura Y; Fujita T; Kumagai Y
J Clin Pharmacol; 2014 Apr; 54(4):446-52. PubMed ID: 24214189
[TBL] [Abstract][Full Text] [Related]
24. Deferasirox does not induce QT/QTc-prolongation in healthy subjects.
Sechaud R; Dumortier T; Balez S
Int J Clin Pharmacol Ther; 2009 May; 47(5):321-7. PubMed ID: 19473594
[TBL] [Abstract][Full Text] [Related]
25. Effects of Celecoxib on the QTc Interval: A Thorough QT/QTc Study.
Kim S; Lee H; Ko JW; Kim JR
Clin Ther; 2019 Nov; 41(11):2204-2218. PubMed ID: 31564512
[TBL] [Abstract][Full Text] [Related]
26. Loxapine delivered as a thermally generated aerosol does not prolong QTc in a thorough QT/QTc study in healthy subjects.
Spyker DA; Voloshko P; Heyman ER; Cassella JV
J Clin Pharmacol; 2014 Jun; 54(6):665-74. PubMed ID: 24375070
[TBL] [Abstract][Full Text] [Related]
27. Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer.
Durairaj C; Ruiz-Garcia A; Gauthier ER; Huang X; Lu DR; Hoffman JT; Finn RS; Joy AA; Ettl J; Rugo HS; Zheng J; Wilner KD; Wang DD
Anticancer Drugs; 2018 Mar; 29(3):271-280. PubMed ID: 29360661
[TBL] [Abstract][Full Text] [Related]
28. Thorough QT/QTc Evaluation of the Cardiac Safety of Enarodustat (JTZ-951), an Oral Erythropoiesis-Stimulating Agent, in Healthy Adults.
Pai SM; Yamada H; Kleiman RB; Zhuo R; Huang QM; Koretomo R
Clin Pharmacol Drug Dev; 2021 Aug; 10(8):884-898. PubMed ID: 34159762
[TBL] [Abstract][Full Text] [Related]
29. Dabigatran does not prolong the QT interval with supratherapeutic exposure: a thorough QT study in healthy subjects.
Ring A; Rathgen K; Stangier J; Reilly P; Clemens A; Friedman J
Clin Drug Investig; 2013 May; 33(5):333-42. PubMed ID: 23519576
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Effect of Contezolid (MRX-I) on the Corrected QT Interval in a Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study in Healthy Chinese Volunteers.
Wu J; Cao G; Wu H; Chen Y; Guo B; Wu X; Yu J; Ni K; Qian J; Wang L; Wu J; Wang Y; Yuan H; Zhang J; Xi Y
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229495
[TBL] [Abstract][Full Text] [Related]
31. Intravenous Amisulpride Does Not Meaningfully Prolong the QTc Interval at Doses Effective for the Management of Postoperative Nausea and Vomiting.
Fox GM; Albayaty M; Walker JL; Xue H; Darpo B
Anesth Analg; 2021 Jan; 132(1):150-159. PubMed ID: 31913911
[TBL] [Abstract][Full Text] [Related]
32. A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects.
Mondal SA; Assaf M; Liu L; O'Mara E
Cancer Chemother Pharmacol; 2016 Feb; 77(2):251-8. PubMed ID: 26754679
[TBL] [Abstract][Full Text] [Related]
33. A thorough QT study to evaluate the effects of singledose exenatide 10 μg on cardiac repolarization in healthy subjects.
Linnebjerg H; Seger M; Kothare PA; Hunt T; Wolka AM; Mitchell MI
Int J Clin Pharmacol Ther; 2011 Oct; 49(10):594-604. PubMed ID: 21961484
[TBL] [Abstract][Full Text] [Related]
34. Influence of age and renal impairment on the steady state pharmacokinetics of filgotinib, a selective JAK1 inhibitor.
Namour F; Fagard L; Van der Aa A; Harrison P; Xin Y; Tasset C
Br J Clin Pharmacol; 2018 Dec; 84(12):2779-2789. PubMed ID: 30088677
[TBL] [Abstract][Full Text] [Related]
35. A thorough QT/QTc study of the effect of fasiglifam, a GPR40 agonist, on cardiac repolarization in healthy adults.
Lee RD; Nudurupati S; Marcinak J; Viswanathan P
Clin Pharmacol Drug Dev; 2015; 4(3):175-83. PubMed ID: 27140797
[TBL] [Abstract][Full Text] [Related]
36. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
de Kam PJ; van Kuijk J; Smeets J; Thomsen T; Peeters P
Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the Effect of Maribavir on Cardiac Repolarization in Healthy Participants: Thorough QT/QTc Study.
Ilic K; Song I; Wu J; Martin P
Clin Transl Sci; 2020 Nov; 13(6):1260-1270. PubMed ID: 32506738
[TBL] [Abstract][Full Text] [Related]
38. Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Tebipenem Pivoxil Hydrobromide on QT/QTc Intervals in Healthy Subjects.
Gupta VK; Maier G; Eckburg P; Morelli L; Lei Y; Jain A; Manyak E; Melnick D
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0014521. PubMed ID: 33875429
[TBL] [Abstract][Full Text] [Related]
39. A supratherapeutic dose of the Janus kinase inhibitor tasocitinib (CP-690,550) does not prolong QTc interval in healthy participants.
Krishnaswami S; Kudlacz E; Wang R; Chan G
J Clin Pharmacol; 2011 Sep; 51(9):1256-63. PubMed ID: 21148043
[TBL] [Abstract][Full Text] [Related]
40. Absence of QTc prolongation with betrixaban: a randomized, double-blind, placebo- and positive-controlled thorough ECG study.
Morganroth J; Gretler DD; Hollenbach SJ; Lambing JL; Sinha U
Expert Opin Pharmacother; 2013 Jan; 14(1):5-13. PubMed ID: 23216423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]